AllianceBernstein’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-54,500
| Closed | -$500K | – | 3406 |
|
|
2021
Q2 | $500K | Buy |
54,500
+11,600
| +27% | +$67.5K | ﹤0.01% | 2812 |
|
|
2021
Q1 | $213K | Hold |
42,900
| – | – | ﹤0.01% | 3040 |
|
|
2020
Q4 | $185K | Hold |
42,900
| – | – | ﹤0.01% | 3010 |
|
|
2020
Q3 | $184K | Sell |
42,900
-2,200
| -5% | -$9.19K | ﹤0.01% | 2972 |
|
|
2020
Q2 | $202K | Buy |
45,100
+9,000
| +25% | +$40.2K | ﹤0.01% | 3004 |
|
|
2020
Q1 | $144K | Buy |
36,100
+4,800
| +15% | +$40.8K | ﹤0.01% | 2886 |
|
|
2019
Q4 | $265K | Hold |
31,300
| – | – | ﹤0.01% | 2822 |
|
|
2019
Q3 | $214K | Buy |
31,300
+5,600
| +22% | +$41.1K | ﹤0.01% | 2922 |
|
|
2019
Q2 | $214K | Buy |
25,700
+6,700
| +35% | +$57.8K | ﹤0.01% | 2946 |
|
|
2019
Q1 | $174K | Buy |
19,000
+500
| +3% | +$5.08K | ﹤0.01% | 2934 |
|
|
2018
Q4 | $203K | Buy |
+18,500
| New | +$233K | ﹤0.01% | 2886 |
|
|
2015
Q2 | – | Sell |
-800
| Closed | -$6K | – | 3354 |
|
|
2015
Q1 | $6K | Hold |
800
| – | – | ﹤0.01% | 3409 |
|
|
2014
Q4 | $6K | Sell |
800
-100
| -11% | -$848 | ﹤0.01% | 3362 |
|
|
2014
Q3 | $8K | Sell |
900
-700
| -44% | -$9.46K | ﹤0.01% | 3315 |
|
|
2014
Q2 | $30K | Buy |
+1,600
| New | +$27.2K | ﹤0.01% | 3178 |
|
Other funds holding KIN
AllianceBernstein's KIN Position: Q3 2021 in Review
AllianceBernstein sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 54,500 shares — an estimated $500K sold.
AllianceBernstein first reported a position in KIN in Q2 2014 and held it in 15 quarters. The position peaked at $500K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- AllianceBernstein reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- AllianceBernstein sold 54,500 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $500K.
- AllianceBernstein first reported a position in Kindred Biosciences, Inc. in Q2 2014 and held it in 15 quarters.
- AllianceBernstein's Kindred Biosciences, Inc. position peaked at $500K in Q2 2021.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.